Global Thrombin (Human) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 120985
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Thrombin (Human) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Thrombin (Human) market size is estimated to be worth US$ 581.3 million in 2021 and is forecast to a readjusted size of USD 715.7 million by 2028 with a CAGR of 3.0% during review period. Biotechnology accounting for % of the Thrombin (Human) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 500IU/Vial segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Thrombin (Human) include Baxter, AMRESCO Inc, BD Biosciences, Life Technologies Corporation, and PromoCell GmbH, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Thrombin (Human) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

500IU/Vial

1000IU/Vial

2500IU/Vial

Market segment by Application can be divided into

Biotechnology

Medicine

Microbiology

Others

The key market players for global Thrombin (Human) market are listed below:

Baxter

AMRESCO Inc

BD Biosciences

Life Technologies Corporation

PromoCell GmbH

Sigma-Aldrich Corporation

Vitrolife AB

CSL

Bayer

Grifols

Octapharma

Shanghai RAAS

Hualan Biological

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Thrombin (Human) product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Thrombin (Human), with price, sales, revenue and global market share of Thrombin (Human) from 2019 to 2022.

Chapter 3, the Thrombin (Human) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Thrombin (Human) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Thrombin (Human) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Thrombin (Human).

Chapter 13, 14, and 15, to describe Thrombin (Human) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Thrombin (Human) Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Thrombin (Human) Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 500IU/Vial

1.2.3 1000IU/Vial

1.2.4 2500IU/Vial

1.3 Market Analysis by Application

1.3.1 Overview: Global Thrombin (Human) Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Biotechnology

1.3.3 Medicine

1.3.4 Microbiology

1.3.5 Others

1.4 Global Thrombin (Human) Market Size & Forecast

1.4.1 Global Thrombin (Human) Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Thrombin (Human) Sales in Volume (2017-2028)

1.4.3 Global Thrombin (Human) Price (2017-2028)

1.5 Global Thrombin (Human) Production Capacity Analysis

1.5.1 Global Thrombin (Human) Total Production Capacity (2017-2028)

1.5.2 Global Thrombin (Human) Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Thrombin (Human) Market Drivers

1.6.2 Thrombin (Human) Market Restraints

1.6.3 Thrombin (Human) Trends Analysis

2 Manufacturers Profiles

2.1 Baxter

2.1.1 Baxter Details

2.1.2 Baxter Major Business

2.1.3 Baxter Thrombin (Human) Product and Services

2.1.4 Baxter Thrombin (Human) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 AMRESCO Inc

2.2.1 AMRESCO Inc Details

2.2.2 AMRESCO Inc Major Business

2.2.3 AMRESCO Inc Thrombin (Human) Product and Services

2.2.4 AMRESCO Inc Thrombin (Human) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 BD Biosciences

2.3.1 BD Biosciences Details

2.3.2 BD Biosciences Major Business

2.3.3 BD Biosciences Thrombin (Human) Product and Services

2.3.4 BD Biosciences Thrombin (Human) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Life Technologies Corporation

2.4.1 Life Technologies Corporation Details

2.4.2 Life Technologies Corporation Major Business

2.4.3 Life Technologies Corporation Thrombin (Human) Product and Services

2.4.4 Life Technologies Corporation Thrombin (Human) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 PromoCell GmbH

2.5.1 PromoCell GmbH Details

2.5.2 PromoCell GmbH Major Business

2.5.3 PromoCell GmbH Thrombin (Human) Product and Services

2.5.4 PromoCell GmbH Thrombin (Human) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6 Sigma-Aldrich Corporation

2.6.1 Sigma-Aldrich Corporation Details

2.6.2 Sigma-Aldrich Corporation Major Business

2.6.3 Sigma-Aldrich Corporation Thrombin (Human) Product and Services

2.6.4 Sigma-Aldrich Corporation Thrombin (Human) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7 Vitrolife AB

2.7.1 Vitrolife AB Details

2.7.2 Vitrolife AB Major Business

2.7.3 Vitrolife AB Thrombin (Human) Product and Services

2.7.4 Vitrolife AB Thrombin (Human) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8 CSL

2.8.1 CSL Details

2.8.2 CSL Major Business

2.8.3 CSL Thrombin (Human) Product and Services

2.8.4 CSL Thrombin (Human) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9 Bayer

2.9.1 Bayer Details

2.9.2 Bayer Major Business

2.9.3 Bayer Thrombin (Human) Product and Services

2.9.4 Bayer Thrombin (Human) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10 Grifols

2.10.1 Grifols Details

2.10.2 Grifols Major Business

2.10.3 Grifols Thrombin (Human) Product and Services

2.10.4 Grifols Thrombin (Human) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11 Octapharma

2.11.1 Octapharma Details

2.11.2 Octapharma Major Business

2.11.3 Octapharma Thrombin (Human) Product and Services

2.11.4 Octapharma Thrombin (Human) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12 Shanghai RAAS

2.12.1 Shanghai RAAS Details

2.12.2 Shanghai RAAS Major Business

2.12.3 Shanghai RAAS Thrombin (Human) Product and Services

2.12.4 Shanghai RAAS Thrombin (Human) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13 Hualan Biological

2.13.1 Hualan Biological Details

2.13.2 Hualan Biological Major Business

2.13.3 Hualan Biological Thrombin (Human) Product and Services

2.13.4 Hualan Biological Thrombin (Human) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Thrombin (Human) Breakdown Data by Manufacturer

3.1 Global Thrombin (Human) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Thrombin (Human) Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Thrombin (Human)

3.4 Market Concentration Rate

3.4.1 Top 3 Thrombin (Human) Manufacturer Market Share in 2021

3.4.2 Top 6 Thrombin (Human) Manufacturer Market Share in 2021

3.5 Global Thrombin (Human) Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Thrombin (Human) Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Thrombin (Human) Market Size by Region

4.1.1 Global Thrombin (Human) Sales in Volume by Region (2017-2028)

4.1.2 Global Thrombin (Human) Revenue by Region (2017-2028)

4.2 North America Thrombin (Human) Revenue (2017-2028)

4.3 Europe Thrombin (Human) Revenue (2017-2028)

4.4 Asia-Pacific Thrombin (Human) Revenue (2017-2028)

4.5 South America Thrombin (Human) Revenue (2017-2028)

4.6 Middle East and Africa Thrombin (Human) Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Thrombin (Human) Sales in Volume by Type (2017-2028)

5.2 Global Thrombin (Human) Revenue by Type (2017-2028)

5.3 Global Thrombin (Human) Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Thrombin (Human) Sales in Volume by Application (2017-2028)

6.2 Global Thrombin (Human) Revenue by Application (2017-2028)

6.3 Global Thrombin (Human) Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Thrombin (Human) Sales by Type (2017-2028)

7.2 North America Thrombin (Human) Sales by Application (2017-2028)

7.3 North America Thrombin (Human) Market Size by Country

7.3.1 North America Thrombin (Human) Sales in Volume by Country (2017-2028)

7.3.2 North America Thrombin (Human) Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Thrombin (Human) Sales by Type (2017-2028)

8.2 Europe Thrombin (Human) Sales by Application (2017-2028)

8.3 Europe Thrombin (Human) Market Size by Country

8.3.1 Europe Thrombin (Human) Sales in Volume by Country (2017-2028)

8.3.2 Europe Thrombin (Human) Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Thrombin (Human) Sales by Type (2017-2028)

9.2 Asia-Pacific Thrombin (Human) Sales by Application (2017-2028)

9.3 Asia-Pacific Thrombin (Human) Market Size by Region

9.3.1 Asia-Pacific Thrombin (Human) Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Thrombin (Human) Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Thrombin (Human) Sales by Type (2017-2028)

10.2 South America Thrombin (Human) Sales by Application (2017-2028)

10.3 South America Thrombin (Human) Market Size by Country

10.3.1 South America Thrombin (Human) Sales in Volume by Country (2017-2028)

10.3.2 South America Thrombin (Human) Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Thrombin (Human) Sales by Type (2017-2028)

11.2 Middle East & Africa Thrombin (Human) Sales by Application (2017-2028)

11.3 Middle East & Africa Thrombin (Human) Market Size by Country

11.3.1 Middle East & Africa Thrombin (Human) Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Thrombin (Human) Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Thrombin (Human) and Key Manufacturers

12.2 Manufacturing Costs Percentage of Thrombin (Human)

12.3 Thrombin (Human) Production Process

12.4 Thrombin (Human) Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Thrombin (Human) Typical Distributors

13.3 Thrombin (Human) Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Thrombin (Human) Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Thrombin (Human) Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Baxter Basic Information, Manufacturing Base and Competitors

Table 4. Baxter Major Business

Table 5. Baxter Thrombin (Human) Product and Services

Table 6. Baxter Thrombin (Human) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. AMRESCO Inc Basic Information, Manufacturing Base and Competitors

Table 8. AMRESCO Inc Major Business

Table 9. AMRESCO Inc Thrombin (Human) Product and Services

Table 10. AMRESCO Inc Thrombin (Human) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. BD Biosciences Basic Information, Manufacturing Base and Competitors

Table 12. BD Biosciences Major Business

Table 13. BD Biosciences Thrombin (Human) Product and Services

Table 14. BD Biosciences Thrombin (Human) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Life Technologies Corporation Basic Information, Manufacturing Base and Competitors

Table 16. Life Technologies Corporation Major Business

Table 17. Life Technologies Corporation Thrombin (Human) Product and Services

Table 18. Life Technologies Corporation Thrombin (Human) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. PromoCell GmbH Basic Information, Manufacturing Base and Competitors

Table 20. PromoCell GmbH Major Business

Table 21. PromoCell GmbH Thrombin (Human) Product and Services

Table 22. PromoCell GmbH Thrombin (Human) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. Sigma-Aldrich Corporation Basic Information, Manufacturing Base and Competitors

Table 24. Sigma-Aldrich Corporation Major Business

Table 25. Sigma-Aldrich Corporation Thrombin (Human) Product and Services

Table 26. Sigma-Aldrich Corporation Thrombin (Human) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 27. Vitrolife AB Basic Information, Manufacturing Base and Competitors

Table 28. Vitrolife AB Major Business

Table 29. Vitrolife AB Thrombin (Human) Product and Services

Table 30. Vitrolife AB Thrombin (Human) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 31. CSL Basic Information, Manufacturing Base and Competitors

Table 32. CSL Major Business

Table 33. CSL Thrombin (Human) Product and Services

Table 34. CSL Thrombin (Human) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 35. Bayer Basic Information, Manufacturing Base and Competitors

Table 36. Bayer Major Business

Table 37. Bayer Thrombin (Human) Product and Services

Table 38. Bayer Thrombin (Human) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 39. Grifols Basic Information, Manufacturing Base and Competitors

Table 40. Grifols Major Business

Table 41. Grifols Thrombin (Human) Product and Services

Table 42. Grifols Thrombin (Human) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 43. Octapharma Basic Information, Manufacturing Base and Competitors

Table 44. Octapharma Major Business

Table 45. Octapharma Thrombin (Human) Product and Services

Table 46. Octapharma Thrombin (Human) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 47. Shanghai RAAS Basic Information, Manufacturing Base and Competitors

Table 48. Shanghai RAAS Major Business

Table 49. Shanghai RAAS Thrombin (Human) Product and Services

Table 50. Shanghai RAAS Thrombin (Human) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 51. Hualan Biological Basic Information, Manufacturing Base and Competitors

Table 52. Hualan Biological Major Business

Table 53. Hualan Biological Thrombin (Human) Product and Services

Table 54. Hualan Biological Thrombin (Human) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 55. Global Thrombin (Human) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)

Table 56. Global Thrombin (Human) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 57. Market Position of Manufacturers in Thrombin (Human), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 58. Global Thrombin (Human) Production Capacity by Company, (K Units): 2020 VS 2021

Table 59. Head Office and Thrombin (Human) Production Site of Key Manufacturer

Table 60. Thrombin (Human) New Entrant and Capacity Expansion Plans

Table 61. Thrombin (Human) Mergers & Acquisitions in the Past Five Years

Table 62. Global Thrombin (Human) Sales by Region (2017-2022) & (K Units)

Table 63. Global Thrombin (Human) Sales by Region (2023-2028) & (K Units)

Table 64. Global Thrombin (Human) Revenue by Region (2017-2022) & (USD Million)

Table 65. Global Thrombin (Human) Revenue by Region (2023-2028) & (USD Million)

Table 66. Global Thrombin (Human) Sales by Type (2017-2022) & (K Units)

Table 67. Global Thrombin (Human) Sales by Type (2023-2028) & (K Units)

Table 68. Global Thrombin (Human) Revenue by Type (2017-2022) & (USD Million)

Table 69. Global Thrombin (Human) Revenue by Type (2023-2028) & (USD Million)

Table 70. Global Thrombin (Human) Price by Type (2017-2022) & (USD/Unit)

Table 71. Global Thrombin (Human) Price by Type (2023-2028) & (USD/Unit)

Table 72. Global Thrombin (Human) Sales by Application (2017-2022) & (K Units)

Table 73. Global Thrombin (Human) Sales by Application (2023-2028) & (K Units)

Table 74. Global Thrombin (Human) Revenue by Application (2017-2022) & (USD Million)

Table 75. Global Thrombin (Human) Revenue by Application (2023-2028) & (USD Million)

Table 76. Global Thrombin (Human) Price by Application (2017-2022) & (USD/Unit)

Table 77. Global Thrombin (Human) Price by Application (2023-2028) & (USD/Unit)

Table 78. North America Thrombin (Human) Sales by Country (2017-2022) & (K Units)

Table 79. North America Thrombin (Human) Sales by Country (2023-2028) & (K Units)

Table 80. North America Thrombin (Human) Revenue by Country (2017-2022) & (USD Million)

Table 81. North America Thrombin (Human) Revenue by Country (2023-2028) & (USD Million)

Table 82. North America Thrombin (Human) Sales by Type (2017-2022) & (K Units)

Table 83. North America Thrombin (Human) Sales by Type (2023-2028) & (K Units)

Table 84. North America Thrombin (Human) Sales by Application (2017-2022) & (K Units)

Table 85. North America Thrombin (Human) Sales by Application (2023-2028) & (K Units)

Table 86. Europe Thrombin (Human) Sales by Country (2017-2022) & (K Units)

Table 87. Europe Thrombin (Human) Sales by Country (2023-2028) & (K Units)

Table 88. Europe Thrombin (Human) Revenue by Country (2017-2022) & (USD Million)

Table 89. Europe Thrombin (Human) Revenue by Country (2023-2028) & (USD Million)

Table 90. Europe Thrombin (Human) Sales by Type (2017-2022) & (K Units)

Table 91. Europe Thrombin (Human) Sales by Type (2023-2028) & (K Units)

Table 92. Europe Thrombin (Human) Sales by Application (2017-2022) & (K Units)

Table 93. Europe Thrombin (Human) Sales by Application (2023-2028) & (K Units)

Table 94. Asia-Pacific Thrombin (Human) Sales by Region (2017-2022) & (K Units)

Table 95. Asia-Pacific Thrombin (Human) Sales by Region (2023-2028) & (K Units)

Table 96. Asia-Pacific Thrombin (Human) Revenue by Region (2017-2022) & (USD Million)

Table 97. Asia-Pacific Thrombin (Human) Revenue by Region (2023-2028) & (USD Million)

Table 98. Asia-Pacific Thrombin (Human) Sales by Type (2017-2022) & (K Units)

Table 99. Asia-Pacific Thrombin (Human) Sales by Type (2023-2028) & (K Units)

Table 100. Asia-Pacific Thrombin (Human) Sales by Application (2017-2022) & (K Units)

Table 101. Asia-Pacific Thrombin (Human) Sales by Application (2023-2028) & (K Units)

Table 102. South America Thrombin (Human) Sales by Country (2017-2022) & (K Units)

Table 103. South America Thrombin (Human) Sales by Country (2023-2028) & (K Units)

Table 104. South America Thrombin (Human) Revenue by Country (2017-2022) & (USD Million)

Table 105. South America Thrombin (Human) Revenue by Country (2023-2028) & (USD Million)

Table 106. South America Thrombin (Human) Sales by Type (2017-2022) & (K Units)

Table 107. South America Thrombin (Human) Sales by Type (2023-2028) & (K Units)

Table 108. South America Thrombin (Human) Sales by Application (2017-2022) & (K Units)

Table 109. South America Thrombin (Human) Sales by Application (2023-2028) & (K Units)

Table 110. Middle East & Africa Thrombin (Human) Sales by Region (2017-2022) & (K Units)

Table 111. Middle East & Africa Thrombin (Human) Sales by Region (2023-2028) & (K Units)

Table 112. Middle East & Africa Thrombin (Human) Revenue by Region (2017-2022) & (USD Million)

Table 113. Middle East & Africa Thrombin (Human) Revenue by Region (2023-2028) & (USD Million)

Table 114. Middle East & Africa Thrombin (Human) Sales by Type (2017-2022) & (K Units)

Table 115. Middle East & Africa Thrombin (Human) Sales by Type (2023-2028) & (K Units)

Table 116. Middle East & Africa Thrombin (Human) Sales by Application (2017-2022) & (K Units)

Table 117. Middle East & Africa Thrombin (Human) Sales by Application (2023-2028) & (K Units)

Table 118. Thrombin (Human) Raw Material

Table 119. Key Manufacturers of Thrombin (Human) Raw Materials

Table 120. Direct Channel Pros & Cons

Table 121. Indirect Channel Pros & Cons

Table 122. Thrombin (Human) Typical Distributors

Table 123. Thrombin (Human) Typical Customers

List of Figures

Figure 1. Thrombin (Human) Picture

Figure 2. Global Thrombin (Human) Revenue Market Share by Type in 2021

Figure 3. 500IU/Vial

Figure 4. 1000IU/Vial

Figure 5. 2500IU/Vial

Figure 6. Global Thrombin (Human) Revenue Market Share by Application in 2021

Figure 7. Biotechnology

Figure 8. Medicine

Figure 9. Microbiology

Figure 10. Others

Figure 11. Global Thrombin (Human) Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028

Figure 12. Global Thrombin (Human) Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Thrombin (Human) Sales (2017-2028) & (K Units)

Figure 14. Global Thrombin (Human) Price (2017-2028) & (USD/Unit)

Figure 15. Global Thrombin (Human) Production Capacity (2017-2028) & (K Units)

Figure 16. Global Thrombin (Human) Production Capacity by Geographic Region: 2022 VS 2028

Figure 17. Thrombin (Human) Market Drivers

Figure 18. Thrombin (Human) Market Restraints

Figure 19. Thrombin (Human) Market Trends

Figure 20. Global Thrombin (Human) Sales Market Share by Manufacturer in 2021

Figure 21. Global Thrombin (Human) Revenue Market Share by Manufacturer in 2021

Figure 22. Thrombin (Human) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 23. Top 3 Thrombin (Human) Manufacturer (Revenue) Market Share in 2021

Figure 24. Top 6 Thrombin (Human) Manufacturer (Revenue) Market Share in 2021

Figure 25. Global Thrombin (Human) Sales Market Share by Region (2017-2028)

Figure 26. Global Thrombin (Human) Revenue Market Share by Region (2017-2028)

Figure 27. North America Thrombin (Human) Revenue (2017-2028) & (USD Million)

Figure 28. Europe Thrombin (Human) Revenue (2017-2028) & (USD Million)

Figure 29. Asia-Pacific Thrombin (Human) Revenue (2017-2028) & (USD Million)

Figure 30. South America Thrombin (Human) Revenue (2017-2028) & (USD Million)

Figure 31. Middle East & Africa Thrombin (Human) Revenue (2017-2028) & (USD Million)

Figure 32. Global Thrombin (Human) Sales Market Share by Type (2017-2028)

Figure 33. Global Thrombin (Human) Revenue Market Share by Type (2017-2028)

Figure 34. Global Thrombin (Human) Price by Type (2017-2028) & (USD/Unit)

Figure 35. Global Thrombin (Human) Sales Market Share by Application (2017-2028)

Figure 36. Global Thrombin (Human) Revenue Market Share by Application (2017-2028)

Figure 37. Global Thrombin (Human) Price by Application (2017-2028) & (USD/Unit)

Figure 38. North America Thrombin (Human) Sales Market Share by Type (2017-2028)

Figure 39. North America Thrombin (Human) Sales Market Share by Application (2017-2028)

Figure 40. North America Thrombin (Human) Sales Market Share by Country (2017-2028)

Figure 41. North America Thrombin (Human) Revenue Market Share by Country (2017-2028)

Figure 42. United States Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Canada Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Mexico Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. Europe Thrombin (Human) Sales Market Share by Type (2017-2028)

Figure 46. Europe Thrombin (Human) Sales Market Share by Application (2017-2028)

Figure 47. Europe Thrombin (Human) Sales Market Share by Country (2017-2028)

Figure 48. Europe Thrombin (Human) Revenue Market Share by Country (2017-2028)

Figure 49. Germany Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. France Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. United Kingdom Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Russia Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Italy Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Asia-Pacific Thrombin (Human) Sales Market Share by Region (2017-2028)

Figure 55. Asia-Pacific Thrombin (Human) Sales Market Share by Application (2017-2028)

Figure 56. Asia-Pacific Thrombin (Human) Sales Market Share by Region (2017-2028)

Figure 57. Asia-Pacific Thrombin (Human) Revenue Market Share by Region (2017-2028)

Figure 58. China Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Japan Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Korea Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. India Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Southeast Asia Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Australia Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South America Thrombin (Human) Sales Market Share by Type (2017-2028)

Figure 65. South America Thrombin (Human) Sales Market Share by Application (2017-2028)

Figure 66. South America Thrombin (Human) Sales Market Share by Country (2017-2028)

Figure 67. South America Thrombin (Human) Revenue Market Share by Country (2017-2028)

Figure 68. Brazil Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Argentina Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Middle East & Africa Thrombin (Human) Sales Market Share by Type (2017-2028)

Figure 71. Middle East & Africa Thrombin (Human) Sales Market Share by Application (2017-2028)

Figure 72. Middle East & Africa Thrombin (Human) Sales Market Share by Region (2017-2028)

Figure 73. Middle East & Africa Thrombin (Human) Revenue Market Share by Region (2017-2028)

Figure 74. Turkey Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Egypt Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Saudi Arabia Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. South Africa Thrombin (Human) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Manufacturing Cost Structure Analysis of Thrombin (Human) in 2021

Figure 79. Manufacturing Process Analysis of Thrombin (Human)

Figure 80. Thrombin (Human) Industrial Chain

Figure 81. Sales Channel: Direct Channel vs Indirect Channel

Figure 82. Methodology

Figure 83. Research Process and Data Source